Thermosemiotic raynaud’s phenomenon for gastrointestinal pathology in children

2019 ◽  
Vol 1 (8) ◽  
pp. 51-57
Author(s):  
S. N. Kolesov

The results of long-term thermal imaging (TI) studies of local peripheral vegetative-vascular disorders in children with diseases of the gastrointestinal tract are summarized. TI cntena for the diagnosis of different variants of Raynaud's phenomenon depending on the gender and age of patients are formulated.

2021 ◽  
Vol 26 (1) ◽  
pp. 56-70
Author(s):  
Eunjung Choi ◽  
Stanislav Henkin

Raynaud’s phenomenon, which is characterized by episodic digital pallor, cyanosis and rubor upon exposure to cold environment or to stress, is relatively common, although the prevalence depends on the climate. Still, it is under-diagnosed, under-treated, and often confused with other conditions. Primary Raynaud’s phenomenon (i.e., Raynaud disease) must be distinguished from secondary Raynaud’s phenomenon (i.e., Raynaud syndrome) as long-term morbidity and outcomes differ vastly between the two conditions. Additionally, the practitioner must differentiate between Raynaud’s phenomenon and related vascular disorders, such as acrocyanosis, pernio, and livedo reticularis. In this article, we review differences between the conditions and suggest an approach to diagnosis and treatment strategy for these disorders.


VASA ◽  
2005 ◽  
Vol 34 (4) ◽  
pp. 243-249 ◽  
Author(s):  
Drinda ◽  
Neumann ◽  
Pöhlmann ◽  
Vogelsang ◽  
Stein ◽  
...  

Background: Prostanoids are used in the treatment of Raynaud’s phenomenon and acral perfusion disorders secondary to collagenosis. In subjective terms, intravenous administration of these agents produces success in more than 50% of patients. The therapeutic outcome of clinical administration of alprostadil or iloprost may vary from individual to individual. Patients and methods: The following variables were analysed in a cross-over study in 27 patients with collagenosis and Raynaud’s phenomenon: plasma viscosity and erythrocyte aggregation (rheological variables), partial pressure of oxygen and laser Doppler flowmetry in the finger region, and lymphocyte phenotyping and interleukin (IL) determinations (immunological variables). Results: Laser Doppler flowmetry revealed significant differences between patients with secondary Raynaud’s phenomenon and a control group of 25 healthy subjects. Laser Doppler readings did not change significantly as a result of the treatments. Therapy with iloprost produced a reduction in IL-1beta, L-selectin (CD 62 L) and IL-6. Conclusion: The change in immunological variables due to iloprost may explain the long-term effects of prostaglandins in the treatment of Raynaud’s phenomenon. From our results it is not possible to infer any preference for iloprost or alprostadil.


2018 ◽  
Vol 98 (2) ◽  
pp. 240-249 ◽  
Author(s):  
Olesya Solheim ◽  
Jacob Skalleberg ◽  
Torhild Warncke ◽  
Kristin Ørstavik ◽  
Claes Tropé ◽  
...  

Author(s):  
Peter Klein-Weigel ◽  
Oliver Sander ◽  
Simone Reinhold ◽  
Jessica Nielitz ◽  
Julia Steindl ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document